Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U H Winkler

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Annals of the New York Academy of Sciences|December 4, 1992
Menstruation: extravascular fibrinolytic activity and reduced fibrinolytic capacityU H Winkler
Zentralblatt Fur Gynakologie|June 18, 1998
[Obesity and thrombotic vascular diseases]U H Winkler
Zentralblatt Fur Gynakologie|January 1, 1995
[Hormone replacement therapy and the cardiovascular system: on the role of hemostasis]U H Winkler
Maturitas|July 1, 1996
Hormone replacement therapy and hemostasis: principles of a complex interactionU H Winkler
Archives of Gynecology and Obstetrics|January 1, 1997
Obesity and haemostasisU H Winkler
Geburtshilfe Und Frauenheilkunde|March 1, 1994
[Hormones and hemostasis]U H Winkler
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|August 26, 1998
Activated protein C resistance and deficiencies of antithrombin III, protein C or protein S and the risk of thromboembolic disease in users of oral contraceptivesU H Winkler
American Journal of Obstetrics and Gynecology|September 30, 1998
Effects on hemostatic variables of desogestrel- and gestodene-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: a reviewU H Winkler
Human Reproduction Update|August 7, 1999
Effects of progestins on cardiovascular diseases: the haemostatic systemU H Winkler
Contraception|December 5, 2000
Hemostatic effects of third- and second-generation oral contraceptives: absence of a causal mechanism for a difference in risk of venous thromboembolismU H Winkler
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Annals of the New York Academy of Sciences|December 4, 1992
Menstruation: extravascular fibrinolytic activity and reduced fibrinolytic capacityU H Winkler
Zentralblatt Fur Gynakologie|June 18, 1998
[Obesity and thrombotic vascular diseases]U H Winkler
Zentralblatt Fur Gynakologie|January 1, 1995
[Hormone replacement therapy and the cardiovascular system: on the role of hemostasis]U H Winkler
Maturitas|July 1, 1996
Hormone replacement therapy and hemostasis: principles of a complex interactionU H Winkler
Archives of Gynecology and Obstetrics|January 1, 1997
Obesity and haemostasisU H Winkler
Geburtshilfe Und Frauenheilkunde|March 1, 1994
[Hormones and hemostasis]U H Winkler
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|August 26, 1998
Activated protein C resistance and deficiencies of antithrombin III, protein C or protein S and the risk of thromboembolic disease in users of oral contraceptivesU H Winkler
American Journal of Obstetrics and Gynecology|September 30, 1998
Effects on hemostatic variables of desogestrel- and gestodene-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: a reviewU H Winkler
Human Reproduction Update|August 7, 1999
Effects of progestins on cardiovascular diseases: the haemostatic systemU H Winkler
Contraception|December 5, 2000
Hemostatic effects of third- and second-generation oral contraceptives: absence of a causal mechanism for a difference in risk of venous thromboembolismU H Winkler
Pageof 6